DETAILED ANSWERS | PLUS RATIONALES | GUARANTEED PASS | LATEST EXAM UPDATE
CORE DOMAINS
* Advanced Pathophysiology
* Complex Pharmacological Management
* Critical Care Assessment and Monitoring
* Ethical Decision-Making in Acute Care
* Regulatory Compliance and Patient Safety
* Perioperative Management
* Chronic Disease Exacerbation Protocols
* Multi-System Organ Failure Interventions
INTRODUCTION
The purpose of this comprehensive exam is to evaluate the clinical proficiency and critical
thinking skills of healthcare professionals in the management of adult patients with complex,
multi-system health conditions. This assessment covers essential knowledge ranging from
advanced pathophysiology to regulatory standards and ethical clinical practices. Utilizing a
mix of multiple-choice and complex scenario-based questions, the exam emphasizes the
practical application of evidence-based interventions in real-world acute and chronic care
settings. Success on this assessment demonstrates the clinician's ability to prioritize patient
safety, integrate complex data points, and deliver effective, high-quality care in demanding
professional environments.
SECTION ONE: QUESTIONS 1–100
1. A patient with severe sepsis presents with a blood pressure of 82/44 mmHg despite
adequate fluid resuscitation. Which vasopressor is considered the first-line agent?
A. Vasopressin B. Epinephrine C. Norepinephrine D. Dopamine
C. Norepinephrine
Explanation: Norepinephrine is the recommended first-line vasopressor for septic shock
due to its potent alpha-adrenergic effects, which increase systemic vascular resistance
without significantly increasing heart rate compared to other agents.
, 2. When managing a patient with acute respiratory distress syndrome (ARDS), what is
the primary goal of lung-protective ventilation?
A. Maintaining a high plateau pressure B. Minimizing volutrauma and barotrauma C.
Promoting rapid carbon dioxide clearance D. Achieving a high tidal volume
B. Minimizing volutrauma and barotrauma
Explanation: The goal of lung-protective ventilation in ARDS is to prevent further alveolar
damage by keeping tidal volumes low (6 mL/kg predicted body weight) and plateau
pressures below 30 cm H2O.
3. A patient is exhibiting signs of intracranial pressure (ICP) elevation following a
traumatic brain injury. Which action is contraindicated?
A. Elevating the head of the bed to 30 degrees B. Maintaining normocapnia C. Administering
prophylactic hyperventilation D. Providing sedation to manage agitation
C. Administering prophylactic hyperventilation
Explanation: Prophylactic hyperventilation is contraindicated in the acute phase of brain
injury because it causes cerebral vasoconstriction, potentially leading to cerebral ischemia.
4. A patient with cirrhosis develops hematemesis. After stabilization, which medication
is most effective in reducing portal pressure?
A. Octreotide B. Furosemide C. Spironolactone D. Lactulose
A. Octreotide
Explanation: Octreotide is a somatostatin analog that causes splanchnic
vasoconstriction, thereby reducing portal venous pressure and controlling variceal bleeding.
5. Which laboratory finding is most indicative of disseminated intravascular coagulation
(DIC)?
A. Elevated fibrinogen levels B. Decreased D-dimer levels C. Prolonged PT and aPTT D.
Thrombocytosis
C. Prolonged PT and aPTT
Explanation: DIC is characterized by the consumption of clotting factors, leading to
prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT),
alongside low platelets and elevated D-dimer.
6. An elderly patient receiving long-term heparin therapy suddenly develops a 50%
drop in platelet count. What is the most likely diagnosis?
,A. Idiopathic thrombocytopenic purpura B. Heparin-induced thrombocytopenia C. Vitamin K
deficiency D. Bone marrow suppression
B. Heparin-induced thrombocytopenia
Explanation: Heparin-induced thrombocytopenia (HIT) is a prothrombotic immune-
mediated disorder that typically presents with a significant decrease in platelet count after
5-10 days of heparin exposure.
7. Which electrolyte imbalance is a common side effect of loop diuretic therapy in
patients with congestive heart failure?
A. Hyperkalemia B. Hypocalcemia C. Hypokalemia D. Hypernatremia
C. Hypokalemia
Explanation: Loop diuretics (e.g., furosemide) inhibit the Na-K-2Cl cotransporter in the
loop of Henle, leading to increased excretion of potassium, sodium, and water.
8. When assessing a patient for suspected diabetic ketoacidosis (DKA), which finding is
expected?
A. Serum pH > 7.45 B. Positive serum ketones C. Blood glucose < 100 mg/dL D. Metabolic
alkalosis
B. Positive serum ketones
Explanation: DKA is characterized by hyperglycemia, metabolic acidosis (pH < 7.30), and
the presence of ketones in the serum or urine due to the breakdown of fatty acids for
energy.
9. A patient is receiving a continuous infusion of vancomycin and develops flushing,
hypotension, and pruritus. What is the most appropriate action?
A. Discontinue the infusion permanently B. Slow the rate of the infusion C. Administer a
bolus of normal saline D. Increase the dose of vancomycin
B. Slow the rate of the infusion
Explanation: These symptoms are indicative of "Red Man Syndrome," which is an
infusion-related reaction caused by rapid histamine release; slowing the infusion rate usually
resolves the symptoms.
10. Which diagnostic study is the gold standard for diagnosing a pulmonary embolism?
A. Chest X-ray B. Ventilation-perfusion (V/Q) scan C. CT pulmonary angiography D. D-dimer
assay
C. CT pulmonary angiography
, Explanation: CT pulmonary angiography (CTPA) allows for direct visualization of the
pulmonary arteries and is highly sensitive and specific for detecting pulmonary emboli.
11. In a patient with autonomic dysreflexia, what is the most common precipitating
factor?
A. Bladder distention B. Emotional distress C. Myocardial infarction D. Hypoglycemia
A. Bladder distention
Explanation: Autonomic dysreflexia is a life-threatening emergency in patients with
spinal cord injuries at or above T6, most commonly triggered by a noxious stimulus such as a
distended bladder or bowel.
12. A patient with myasthenia gravis is at risk for a myasthenic crisis. What clinical sign
indicates respiratory muscle involvement?
A. Ptosis B. Diplopia C. Decreased negative inspiratory force D. Extremity weakness
C. Decreased negative inspiratory force
Explanation: A decrease in negative inspiratory force (NIF) is a clinical indicator of
diaphragmatic and intercostal muscle weakness, signaling impending respiratory failure in
myasthenia gravis.
13. What is the primary nursing intervention for a patient experiencing a tonic-clonic
seizure?
A. Restraining the patient's limbs B. Inserting an oral airway C. Ensuring patient safety and
protecting the head D. Administering oral anticonvulsants
C. Ensuring patient safety and protecting the head
Explanation: The primary goal during a seizure is to prevent injury by clearing the area,
cushioning the head, and placing the patient in a side-lying position to maintain an airway.
14. Which arterial blood gas (ABG) result would you expect in a patient with chronic
obstructive pulmonary disease (COPD) experiencing acute respiratory failure?
A. pH 7.35, PaCO2 45 mmHg, HCO3 24 mEq/L B. pH 7.25, PaCO2 60 mmHg, HCO3 30 mEq/L
C. pH 7.50, PaCO2 30 mmHg, HCO3 22 mEq/L D. pH 7.40, PaCO2 40 mmHg, HCO3 24 mEq/L
B. pH 7.25, PaCO2 60 mmHg, HCO3 30 mEq/L
Explanation: This ABG reflects uncompensated or partially compensated respiratory
acidosis, which is common in acute-on-chronic respiratory failure in COPD patients.
15. What is the therapeutic range for serum phenytoin levels?